Merial reports U.S. patent office confirms 'patentability' of veterinary flea and tick product
Duluth, Ga. -- Merial reports that the United States Patent and Trademark Office "reconfirmed the patentability" of formulation claims covering Merial's Frontline® Plus.
Duluth, Ga. --
Merial reports that the United States Patent and Trademark Office "reconfirmed the patentability" of formulation claims covering Merial's Frontline® Plus.
"The ultimate result is that we expect some of the products infringing the formulation claims to be removed from the market," says Dr. Judy Jarecki-Black, Esq. Merial's head of intellectual property.
The government statement confirms the patentability of Merial's inventions directed at fipronil and (S)-methoprene containing spot-on compositions, Jarecki-Black says in a prepared statement.
Merial reports that it is pursuing litigation to protect its patent on the popular flea and tick brand.
"We plan to continue to vigorously defend our patent rights and continue our strong support of the veterinary profession," she says.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
